@article{8592414038e3435cbfb26cd9d0a6f1e3,
title = "Cost-Utility of Venetoclax Plus Obinutuzumab for Treatment-Naive Patients with Chronic Lymphocytic Leukemia without Del17p/TP53-Mutation Compared to Chlorambucil Plus Obinutuzumab",
author = "Matilde Slot and Niemann, {Carsten Utoft} and Risor, {Bettina Wulff} and Ehlers, {Lars Holger} and Emelie Rotbain",
note = "Abstrakt No. 902; 64th ASH Annual Meeting & Exposition, ASH 2022 ; Conference date: 10-12-2022 Through 13-12-2022",
year = "2022",
month = nov,
day = "15",
doi = "10.1182/blood-2022-158143",
language = "English",
volume = "140",
pages = "2163--2164",
journal = "Blood",
issn = "0006-4971",
publisher = "AMER SOC HEMATOLOGY",
number = "Suppl. 1",
}